Genomic and Transcriptomic Characterization of Natural Killer T Cell LymphomaJie Xiong, Weili Zhao, Yu Hu et al.|Cancer Cell|2020Cited by 238
SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potentialJie Xiong, Weili Zhao, Nan Wang et al.|EBioMedicine|2021Cited by 51
Prognostic factors of Chinese patients with T/NK-cell lymphoma: a single institution study of 170 patientsPengpeng Xu, Weili Zhao, Yan Wang et al.|Medical Oncology|2011Cited by 25
Case Report: Successful Management of a Refractory Plasmablastic Lymphoma Patient With Tislelizumab and LenalidomideLili Cheng, Weili Zhao, Qi Song et al.|Frontiers in Immunology|2021Cited by 15